Title: Cardinal Health Inc (CAH) 10K Annual Reports & 10Q SEC Filings
URL: https://last10k.com/sec-filings/cah

HOME


LOGIN


PREMIUM


FREE TRIAL


SEC FILINGS


STOCK SCREENERS


EARNINGS


TRENDING


STOCKTWITS


INSIDER TRADING


SENTIMENT ANALYSIS


MANAGER PORTFOLIOS


LATE CORPORATE NEWS






				 



Cardinal Health Inc (CAH) SEC Filing 10-K Annual Report for the fiscal year ending Sunday, June 30, 2024


Home
SEC Filings
Cardinal Health Inc (CAH)
10-K Annual Report Wed Aug 14 2024






SEC Filings



 
CAH Valuations





Intrinsic Value





Financial Stability





Financial Ratios





Insider Trades





Manager Portfolios





Notifications





 
CAH Annual Reports
				  





10-K Annual Report August 2024


PDF

PDF


Select PDF Feature:
Include Exhibits
Highlight YoY Changes
Highlight Sentiment

10-K Only


Word
Excel
CSV


Table of Contents
Introduction
Management's Discussion and Analysis of Financial Condition and Results of Operations
Explanation and Reconciliation of NonGAAP Financial Measures
Quantitative and Qualitative Disclosures about Market Risk
Business
Risk Factors
Cybersecurity
Properties
Legal Proceedings
Market for Registrant's Common Equity
Financial Statements and Supplementary Data
Directors, Executive Officers and Corporate Governance
Exhibits
Form 10K Cross Reference Index
Signatures








									10-K Annual Report August 2023																






									10-K Annual Report August 2022																






									10-K Annual Report August 2021																






									10-K Annual Report August 2020																






									10-K Annual Report August 2019																






									10-K Annual Report August 2018																






									10-K Annual Report August 2017																






									10-K Annual Report August 2016																






CAH Quarterly Reports
				  





									10-Q Quarterly Report May 2024																






									10-Q Quarterly Report February 2024																






									10-Q Quarterly Report November 2023																






									10-Q Quarterly Report May 2023																






									10-Q Quarterly Report February 2023																






									10-Q Quarterly Report November 2022																






									10-Q Quarterly Report May 2022																






									10-Q Quarterly Report February 2022																






									10-Q Quarterly Report November 2021																






									10-Q Quarterly Report May 2021																






CAH Corporate News
				  





									Financial ExhibitNew AgreementNew Financial Obligation																	October 2024







									Event for Officers																	September 2024







									Earnings ReleaseFinancial ExhibitRegulated Disclosure																	August 2024







									Earnings ReleaseFinancial ExhibitRegulated Disclosure																	May 2024







									Financial ExhibitRegulated Disclosure																	April 2024







									Financial ExhibitRegulated Disclosure																	April 2024







									Event for OfficersFinancial ExhibitRegulated Disclosure																	February 2024







									Financial ExhibitNew AgreementNew Financial ObligationOther Events																	February 2024







									Earnings ReleaseFinancial ExhibitRegulated Disclosure																	February 2024







									Earnings ReleaseFinancial ExhibitRegulated Disclosure																	January 2024













Last10K.com | 10-K Annual Report Wed Aug 14 2024






Cardinal Health Inc


													CIK: 721371
																										Ticker: CAH




Earnings Press Release
 10-K Annual Report
 10-K YoY Changes
 Annual Proxy




Cardinal Health Inc

HISTORY
TOOLS


CIK: 721371
Ticker: CAH




Exhibit 99.1FOR IMMEDIATE RELEASECardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance•Fourth quarter revenue increased 12% to $59.9 billion•Fourth quarter GAAP1 operating earnings were $401 million and GAAP diluted EPS was $0.96•Fourth quarter non-GAAP operating earnings increased 14% to $605 million and non-GAAP diluted EPS increased 29% to $1.84•Fiscal Year 2024 operating cash flow and adjusted free cash flow reached all-time highs of $3.8 billion and $3.9 billion, respectively•Fiscal year 2025 non-GAAP EPS guidance raised to $7.55 to $7.70, from at least $7.50DUBLIN, Ohio, August 14, 2024 – Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2024 revenues of $59.9 billion, an increase of 12% from the prior year. GAAP operating earnings were $401 million and GAAP diluted earnings per share (EPS) were $0.96. Non-GAAP operating earnings increased 14% to $605 million, driven primarily by segment profit increases in Global Medical Products and Distribution (GMPD) and Pharmaceutical and Specialty Solutions. Non-GAAP diluted earnings per share (EPS) increased 29% to $1.84 in the quarter, reflecting the increase in non-GAAP operating earnings across the business, lower interest and other expense, a lower non-GAAP effective tax rate and a lower share count.Fiscal year 2024 revenues were $226.8 billion, an 11% increase from fiscal year 2023. GAAP operating earnings were $1.2 billion and GAAP diluted EPS was $3.45. Non-GAAP operating earnings increased 16% to $2.4 billion, driven primarily by segment profit increases in GMPD and Pharmaceutical and Specialty Solutions. Non-GAAP diluted EPS increased 29% to $7.53 for the year, reflecting the increase in non-GAAP operating earnings across the business, lower interest and other expense, a lower non-GAAP effective tax rate and a lower share count following in-year share repurchases.“Fiscal 2024 marked a year of strong operational execution and record financial results, delivered in tandem with key strategic progress in the portfolio,” said Jason Hollar, CEO of Cardinal Health. "We delivered robust cash flow generation, continued profit growth in the Pharmaceutical and Specialty Solutions segment and significant improvement driven by our GMPD Improvement Plan. We enter the new fiscal year with momentum and confidence, evidenced by our raised fiscal year 2025 guidance."The following information was filed by Cardinal Health Inc (CAH) on Wednesday, August 14, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release. 

Please wait while we load the requested 10-K report or click the link below:https://last10k.com/sec-filings/report/721371/000072137124000056/cah-20240630.htm


View differences made from one year to another to evaluate Cardinal Health Inc's financial trajectory





Sample 10-K Year-over-Year (YoY) Comparison



Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cardinal Health Inc.

Continue







Assess how Cardinal Health Inc's management team is paid from their Annual Proxy





Screenshot example of actual Proxy Statement




Cardinal Health Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors


Continue














SEC Filing Tools




 Sentiment
 Sections
 Exhibits
 Stats


 



 Rating					
Learn More










Filter Sentiment:



All






Positive




Negative





Filter Category:




All






Legal





Financial







Revenue






M & A






Other






Filter Subcategory:




All






Cash Flow






Expense





Earnings







Product






Shares






Debt






Income






Geography






Dividend






Other







 Inside Cardinal Health Inc's 10-K Annual Report:


 Legal - Other   Highlight
Changes in our current estimates due to unanticipated market conditions, tax law changes or other factors could have a material effect on our ability to utilize deferred tax assets.



 Financial - Cash Flow   Highlight
operating cash flow, or otherwise fails to meet current financial plans, or if there were changes to any other key assumptions used in the tests, the reporting unit could incur a goodwill impairment in a future period.

 Other - Other   Highlight
Other people applying reasonable judgment to the same facts and circumstances could develop different estimates.

 Other - Other   Highlight
Our assumptions and estimates around uncertain tax positions require significant judgment; the actual amount of tax benefit related to uncertain tax positions may differ from these estimates.

 Financial - Expense   Highlight
Conversely, if there is a decrease in inventory levels that have experienced a pharmaceutical price decline, the result generally will be an increase in future cost of products sold as our older inventory is held at a higher cost.

 Other - Other
We self-insure through a wholly-owned...Read more

 Financial - Expense
Historically, prices for branded pharmaceuticals...Read more

 Financial - Earnings
Fiscal 2023 GMPD segment profit...Read more

 Financial - Cash Flow
A decrease in future cash...Read more

 Other - Other
Our actions to increase prices...Read more

 Financial - Earnings
These net inflationary impacts negatively...Read more

 Revenue - Product
Fiscal 2023 GMPD segment revenue...Read more

 Other - Other
Our estimates for selling prices...Read more

 Financial - Earnings
Fiscal 2023 Pharmaceutical and Specialty...Read more

 Other - Other
During fiscal 2024, under our...Read more

 Financial - Earnings
Fiscal 2024 Pharmaceutical and Specialty...Read more

 Revenue - Product
Fiscal 2024 Other revenue increased...Read more

 Financial - Shares
We also recognized income of...Read more

 Other - Other
In this report, we present...Read more

 Revenue - Product
At June 30, 2024, we had...Read more

 Financial - Cash Flow
We expect the unwinding of...Read more

 Revenue - Product
Fiscal 2023 Other revenue increased...Read more

 Financial - Cash Flow
In particular, we expect the...Read more

 M & A - Other
We expect the Specialty Networks...Read more

 Other - Other
A portion of the proceeds...Read more

 Revenue - Product
Fiscal 2024 Pharmaceutical and Specialty...Read more

 Revenue - Product
Fiscal 2024 GMPD segment revenue...Read more

 Other - Other
We evaluated the materiality of...Read more

 Other - Other
We evaluated the materiality of...Read more

 Revenue - Product
Fiscal 2023 Pharmaceutical and Specialty...Read more

 Other - Other
At June 30, 2024, we had...Read more

 Revenue - Product
During fiscal 2024, we saw...Read more

 Other - Other
recognized is measured as the...Read more

 Legal - Other
Other estimates are based on...Read more

 Financial - Cash Flow
The use of alternate estimates...Read more

 Other - Other
Effective January 1, 2024, our...Read more

 Financial - Expense
In addition, decreases in some...Read more

 Other - Other
We regularly review contingencies and...Read more

 Financial - Expense
We believe that the average...Read more

 Financial - Expense
Fiscal 2024 and 2023 interest...Read more

 Other - Other
Using LIFO, if there is...Read more

 Other - Other
Specialty Networks’ PPS Analytics platform...Read more

 Financial - Earnings
Fiscal 2024 Other segment profit...Read more

 Other - Other
Our qualitative evaluation considers the...Read more

 Financial - Expense
During fiscal 2022, restructuring also...Read more

 M & A - Other
The acquisition further expands our...Read more

 Financial - Earnings
Fiscal 2023 Other segment profit...Read more

 Financial - Debt
The proceeds of the notes...Read more

 Other - Other
This impairment charge was driven...Read more

 Financial - Shares
On May 7, 2024, our...Read more

 Other - Other
This segment also provides services...Read more

 Financial - Income
We also recognized income of...Read more

 Revenue - Product
Revenue increased 11 percent to...Read more

 Financial - Expense
We provide pharmaceuticals and medical...Read more

 Revenue - Product
We experienced Cardinal Health brand...Read more

 Other - Other
The increase was partially offset...Read more

 Financial - Shares
On June 7, 2023, our...Read more

 Financial - Expense
During fiscal 2023 and 2022,...Read more

 Other - Other
Prior-period goodwill impairment charges related...Read more

 Financial - Earnings
The performance of our Pharmaceutical...Read more

 Financial - Expense
Fiscal 2023 SG&A expenses increased...Read more

 Financial - Income
We also recognized income of...Read more

 Revenue - Geography
We file income tax returns...Read more

 Revenue - Geography
We file income tax returns...Read more

 Other - Other
Purchased goodwill and intangible assets...Read more

 Other - Other
In July 2024, we made...Read more

 Financial - Expense
The decrease in at-Home Solutions...Read more

 Financial - Income
Our determination of estimated fair...Read more

 Financial - Income
During fiscal 2023, we recognized...Read more

 Other - Other
We connect patients, providers, payers,...Read more

 Financial - Dividend
During fiscal 2024, we paid...Read more

 Financial - Expense
Fiscal 2024 SG&A expenses increased...Read more

 Financial - Debt
(1)Represents maturities of our long-term...Read more

 Other - Other
The majority of the prepayment...Read more

 Financial - Earnings
This decline in gross margin...Read more

 Other - Other
Cardinal Health, Inc., an Ohio...Read more

 Other - Other
specific categories of inventory, age and...Read more

 Other - Other
During fiscal 2023, net cash...Read more

 Other - Other
The cash and equivalents balance...Read more

 Financial - Income
Our determination of estimated fair...Read more

 Other - Other
The amounts of future annual...Read more

 Other - Other
During fiscal 2024, 2023, and...Read more

 Other - Other
We expect capital expenditures in...Read more

 Revenue - Product
In September 2023, Cardinal Health...Read more

 Financial - Cash Flow
In addition to cash and...Read more

 Revenue - Product
In September 2022, we renewed...Read more

 Financial - Shares
As of June 30, 2024, we...Read more

 Other - Other
In addition, contracts that can...Read more

 Other - Other
New challenges related to future...Read more

 Other - Other
New challenges related to future...Read more

 Legal - Other
We have incurred, and may...Read more

 Other - Other
Fluctuations in the effective tax...Read more

 Legal - Other
(4)A purchase obligation is defined...Read more

 Other - Other
At June 30, 2024, our cash...Read more

 Other - Other
We concluded that there were...Read more

 Other - Other
Specialty Networks creates clinical and...Read more

 Other - Other
Capital expenditures during fiscal 2024...Read more

 Financial - Earnings
The frequency, timing, magnitude and...Read more

 Other - Other
Our cash and equivalents balance...Read more

 Other - Other
Our cash and equivalents balance...Read more

 Other - Other
However, the quantitative test resulted...Read more

 Other - Other
During fiscal 2024, we paid...Read more

 Other - Other
•Other: This is comprised of...Read more

 Other - Other
These other immaterial errors were...Read more

 Other - Other
These other immaterial errors were...Read more

 Revenue - Product
(1)Corporate revenue consists of the...Read more

 Other - Other
Our cash and equivalents balance...Read more

 Other - Other
Accordingly, we allocated $90 million...Read more

 Other - Other
If so, then a quantitative...Read more

 Financial - Expense
At June 30, 2024 and 2023,...Read more

 Other - Other
(5)Represents future cash obligations under...Read more

 Other - Other
There is an option to...Read more

 Other - Other
Our previously reported goodwill balances...Read more

 Other - Other
Accordingly, we were required to...Read more

 Other - Other
Goodwill impairment testing involves judgment,...Read more

 Revenue - Geography
In fiscal 2024, we returned...Read more

 Other - Other
We also performed annual impairment...Read more

 Financial - Expense
However, these inflationary costs are...Read more

 Revenue - Geography
In connection with this extension,...Read more

 Other - Other
The evaluation and implementation of...Read more

 Other - Other
Our Pharmaceutical and Specialty Solutions...Read more

 Other - Other
Amounts have been revised to...Read more

 Other - Other
For tax benefits that do...Read more

 Legal - Other
Examples of such contingencies include...Read more

 Other - Other
Purchase obligations and other payments...Read more

 Other - Other
During the three months ended...Read more

 Other - Other
This change in segment structure...Read more

 Financial - Expense
For certain types of exposures,...Read more

 Financial - Earnings
The net inflationary impacts were...Read more

 Financial - Earnings
Beginning in fiscal 2022, GMPD...Read more

 Other - Other
The impairment test for indefinite-lived...Read more

 Revenue - Geography
At June 30, 2024, foreign earnings...Read more

 Financial - Expense
During fiscal 2024, we recognized...Read more

 Financial - Earnings
We expect the expiration of...Read more

 Financial - Earnings
Fiscal 2024 GMPD segment profit...Read more

 Other - Other
On April 22, 2024, we...Read more

 Other - Other
During the three months ended...Read more

 Financial - Cash Flow
Changes in working capital, which...Read more

 Financial - Earnings
The timing, magnitude and profit...Read more

 Financial - Income
After applying the valuation allowances,...Read more

 Financial - Earnings
We expect COVID-19 vaccine distribution...Read more

 Other - Other
Since that time, we have...Read more

 Other - Other
With few exceptions, we are...Read more

 Other - Other
Estimating the fair value of...Read more

 Financial - Earnings
A hypothetical 0.1 percent increase...Read more

 Other - Other
These are primarily merchandise inventories...Read more

 Revenue - Product
This increase was partially offset...Read more

 Other - Other
With few exceptions, we are...Read more

 Other - Other
Qualitative factors are first assessed...Read more

 Revenue - Product
In connection with the preparation...Read more

 Revenue - Product
In connection with the preparation...Read more

 Other - Other
Goodwill impairment testing involves a...Read more

 M & A - Other
If we decide to engage...Read more

 Other - Other
For example, if we were...Read more

 Legal - Other
In April 2023, we executed...Read more

 Financial - Expense
Self-insurance accruals include an estimate...Read more

 Financial - Expense
This expense was partially offset...Read more

 Legal - Other
To project future IVC claim...Read more

 Financial - Earnings
GMPD segment profit was adversely...Read more

 Legal - Other
We develop and periodically update...Read more

 Other - Other
A reporting unit is defined...Read more

 Other - Other
During our fiscal 2024 annual...Read more

 Revenue - Geography
Our GMPD segment manufactures, sources...Read more

 Financial - Expense
Restructuring and employee severance costs...Read more

 Other - Other
The quantitative goodwill impairment test...Read more

 Financial - Expense
These increases were partially offset...Read more

 Financial - Expense
These increases were partially offset...Read more

 Financial - Expense
As such, we did not...Read more

 Other - Other
We have elected to bypass...Read more

 Financial - Cash Flow
We currently believe that, based...Read more

 Revenue - Geography
In addition to distributing Cardinal...Read more

 Legal - Other
During fiscal 2022, we recognized...Read more

 Revenue - Geography
In January 2024, we made...Read more

 Financial - Expense
The increase in fiscal 2024...Read more

 Financial - Earnings
Gross margin rate declined 23...Read more

 Financial - Expense
generally will be a decrease...Read more

 Other - Other
If actual conditions are less...Read more

 Other - Other
Any adjustments for changes in...Read more

 Financial - Earnings
Gross margin rate declined 8...Read more

 Financial - Cash Flow
Additionally, we assigned a weighting...Read more

 Other - Other
Deferred tax assets and liabilities...Read more

 Other - Other
We believe that our estimates...Read more

 Financial - Earnings
This decline in gross margin...Read more

 Financial - Expense
We believe the reserve maintained...Read more

 Legal - Other
We accrue for contingencies related...Read more

 Financial - Expense
During fiscal 2024 and 2023,...Read more

 Financial - Earnings
Distribution of these vaccines had...Read more

 Other - Other
We operate in a complex...Read more

 Legal - Other
For claims incurred but not...Read more

 Other - Other
In May 2023, we extended...Read more

 Revenue - Product
We reserve for inventory obsolescence...Read more

 Revenue - Product
Our previously reported segment results...Read more

 M & A - Other
On March 18, 2024, we...Read more

 Legal - Other
These settlements will not resolve...Read more

 M & A - Other
On March 18, 2024, we...Read more

 M & A - Other
On March 18, 2024, we...Read more

 Other - Other
The purchase obligation amounts disclosed...Read more

 Other - Other
We determine our allowance for...Read more

 Other - Other
At this time, we are...Read more

 Other - Other
Our qualitative evaluation requires the...Read more

 Financial - Cash Flow
We assigned a weighting of...Read more

 Financial - Expense
Our remaining inventory, including inventory...Read more

 Financial - Income
(3)Represents minimum operating lease obligations...Read more

 Financial - Earnings
We expect these inflationary impacts...Read more

 Financial - Expense
The decrease in Fiscal 2024...Read more

 Other - Other
As of June 30, 2024,...Read more

 Other - Other
We also assessed GMPD's goodwill...Read more

 Other - Other
We also assessed goodwill for...Read more



 
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report





Audit Information





Cover Page





Consolidated Balance Sheets





Consolidated Balance Sheets (Parenthetical)





Consolidated Statements Of Cash Flows





Consolidated Statements Of Comprehensive Income/(Loss)





Consolidated Statements Of Earnings/(Loss)





Consolidated Statements Of Shareholders' Equity/(Deficit)





Accounting Changes And Error Corrections





Accounting Changes And Error Corrections (Details)





Accounting Changes And Error Corrections (Tables)





Basis Of Presentation And Summary Of Significant Accounting Policies





Basis Of Presentation And Summary Of Significant Accounting Policies (Assets Held For Sale) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Components Of Property And Equipment) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Leases) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Dividends) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Goodwill And Other Intangible Assets) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Inventories) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Major Customers) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Property And Equipment) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Receivables) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Sales Returns And Allowances) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Shipping And Handling) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Narrative, Vendor Reserves) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Policies)





Basis Of Presentation And Summary Of Significant Accounting Policies (Revenue And Gross Trade Receivables Percentage By Major Customers) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Revision Of Consolidated Balance Sheet) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Revision Of Consolidated Statement Of Comprehensive Income (Loss)) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Revision Of Consolidated Statements Of Cash Flows) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Revision Of Consolidated Statements Of Earnings (Loss)) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Revision Of Consolidated Statements Of Shareholders' Equity/(Deficit)) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Share-Based Compensation) (Details)





Basis Of Presentation And Summary Of Significant Accounting Policies (Tables)





Basis Of Presentation And Summary Of Significant Accounting Policies Loss Contingencies (Details)





Business Combinations And Asset Acquisitions





Business Combinations And Asset Acquisitions (Details)





Business Combinations And Asset Acquisitions (Tables)





Commitments, Contingent Liabilities And Litigation





Commitments, Contingent Liabilities And Litigation (Details)





Discontinued Operations And Disposal Groups





Divestitures (Details)





Earnings Per Share Attributable To Cardinal Health, Inc.





Earnings Per Share Attributable To Cardinal Health, Inc. (Narrative) (Details)





Earnings Per Share Attributable To Cardinal Health, Inc. (Reconciliation Of Common Shares Used To Compute Basic And Diluted Eps) (Details)





Earnings Per Share Attributable To Cardinal Health, Inc. (Tables)





Fair Value Measurements





Fair Value Measurements (Fair Value Of Assets And Liabilities Measured On A Recurring Basis) (Details)





Fair Value Measurements (Tables)





Financial Instruments





Financial Instruments (Narrative) (Details)





Financial Instruments (Schedule Of Fair Value Gain Loss Derivative Instrument) (Details)





Financial Instruments (Schedule Of Gain/(Loss) Included In Aoci For Derivative Instruments Designated As Cash Flow Hedges) (Details)





Financial Instruments (Schedule Of Gain/(Loss) Reclassified From Aoci Into Earnings For Derivative Instruments Designated As Cash Flow Hedges) (Details)





Financial Instruments (Schedule Of Gain/(Loss) Recognized In Earnings For Derivatives Not Designated As Hedging Instrument) (Details)





Financial Instruments (Schedule Of Gain/(Loss) Recognized In Earnings For Interest Rate Contracts Designated As Fair Value Hedges) (Details)





Financial Instruments (Schedule Of Outstanding Instruments, Cash Flow Hedges) (Details)





Financial Instruments (Schedule Of Outstanding Instruments, Economic Hedges) (Details)





Financial Instruments (Schedule Of Outstanding Instruments, Fair Value Hedges) (Details)





Financial Instruments (Schedule Of The Fair Value Of Assets And Liabilities Related To Derivatives Designated As Hedging Instruments) (Details)





Financial Instruments (Summary Of Estimated Fair Value Of Long-Term Obligations And Other Short-Term Borrowings) (Details)





Financial Instruments (Tables)





Goodwill And Other Intangible Assets





Goodwill And Other Intangible Assets (Narrative) (Details)





Goodwill And Other Intangible Assets (Schedule Of Goodwill By Reportable Segment) (Details)





Goodwill And Other Intangible Assets (Schedule Of Intangible Assets) (Details)





Goodwill And Other Intangible Assets (Tables)





Income Taxes





Income Taxes (Narrative) (Details)





Income Taxes (Schedule Of Components Of Income Tax Expense (Benefit), Current And Deferred) (Details)





Income Taxes (Schedule Of Deferred Tax Assets And Liabilities After Netting By Tax Jurisdiction) (Details)





Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details)





Income Taxes (Schedule Of Effective Income Tax Rate Reconciliation) (Details)





Income Taxes (Schedule Of Income Before Income Tax, Domestic And Foreign) (Details)





Income Taxes (Schedule Of Unrecognized Tax Benefits Roll Forward) (Details)





Income Taxes (Tables)





Insider Trading Arrangements





Insider Trading Policies And Procedures





Leases





Leases (Details)





Leases (Tables)





Leases Schedule Of Future Lease Payments (Details)





Leases Schedule Of Lease Costs (Details)





Leases Supplemental Balance Sheet Information (Details)





Leases Supplemental Cash Flow Information (Details)





Long-Term Obligations And Other Short-Term Borrowings





Long-Term Obligations And Other Short-Term Borrowings (Tables)





Long-Term Obligations And Other Short-Term Borrowings Long-Term Debt (Details)





Long-Term Obligations And Other Short-Term Borrowings Narrative (Details)





Long-Term Obligations And Other Short-Term Borrowings Other Financing Arrangements (Details)





Long-Term Obligations And Other Short-Term Borrowings Summary Of Debt (Details)





Pay Vs Performance Disclosure





Restructuring And Employee Severance





Restructuring And Employee Severance (Activity Related To Restructuring And Employee Severance Costs) (Details)





Restructuring And Employee Severance (Liabilities Associated With Restructuring And Employee Severance Activities) (Details)





Restructuring And Employee Severance (Tables)





Schedule Ii - Valuations And Qualifying Accounts





Schedule Ii - Valuations And Qualifying Accounts (Details)





Segment Information





Segment Information (Assets By Reportable Segment) (Details)





Segment Information (Depreciation And Amortization And Additions To Property And Equipment By Reportable Segment) (Details)





Segment Information (Narrative) (Details)





Segment Information (Revenue By Reportable Segment) (Details)





Segment Information (Segment Profit By Reportable Segment) (Details)





Segment Information (Tables)





Segment Information Property And Equipment, Net By Geographic Area) (Details)





Share-Based Compensation





Share-Based Compensation (Additional Data Related To Performance Share Unit Activity) (Details)





Share-Based Compensation (Additional Data Related To Restricted Share Unit Activity) (Details)





Share-Based Compensation (Narrative) (Details)





Share-Based Compensation (Schedule Of All Transactions Related To Performance Share Units Under The Plans) (Details)





Share-Based Compensation (Schedule Of All Transactions Related To Restricted Share Units Under The Plans) (Details)





Share-Based Compensation (Schedule Of Total Share-Based Compensation Expense By Type Of Award) (Details)





Share-Based Compensation (Tables)





Shareholders' Equity





Shareholders' Equity (Changes In The Accumulated Other Comprehensive Income (Loss)) (Details)





Shareholders' Equity (Narrative) (Details)





Shareholders' Equity (Tables)




 
Material Contracts, Statements, Certifications & more
Cardinal Health Inc provided additional information to their SEC Filing as exhibits





Exhibit 10.1 10: Material Contract





Exhibit 10.1 11: Material Contract





Exhibit 10.9 4: Material Contract





Exhibit 10.9 5: Material Contract





Exhibit 19: Report Composed To Security Holders





Exhibit 21.1: Subsidaries Of The Registrant





Exhibit 23.1: Consents Of Experts And Counsel





Exhibit 31.1: Rule 13A-14(A)/15D-14(A) Certification





Exhibit 31.2: Rule 13A-14(A)/15D-14(A) Certification





Exhibit 32.1: Section 1350 Certification





Exhibit 97: Ex-97





Exhibit 99.1: Additional Exhibits






Ticker: CAH CIK: 721371
Form Type: 10-K Annual Report
Accession Number: 0000721371-24-000056
Submitted to the SEC: Wed Aug 14 2024 8:47:07 AM EST
Accepted by the SEC: Wed Aug 14 2024
Period:  Sunday, June 30, 2024
Industry: Wholesale Drugs Proprietaries And Druggists Sundries						
External Resources:
 Stock Quote
 Social Media
 SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/cah/0000721371-24-000056.htm








About 
											Contact 
											Help 
											API 
											Privacy 
											Terms 
									


© 2012 - 2024 Last10K.com All Rights Reserved









×
You're Signed Out
Sign in for the full experience


Sign in
Join Now








Intrinsic Value Calculator








Screenshot of intrinsic value for AT&T (2019)




Last10K.com Member Feature

Our Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
Continue












Never Miss A New SEC Filing Again








Screenshot taken from Gmail for a new 10-K Annual Report




Last10K.com Member Feature

Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news
Continue












We Highlighted This SEC Filing For You








Screenshot taken from Wynn's 2018 10-K Annual Report




Last10K.com Member Feature

Read positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q
Continue












Widen Your SEC Filing Reading Experience








Screenshot taken from Adobe Inc.'s 10-Q Quarterly Report




Last10K.com Member Feature

Remove data columns and navigations in order to see much more filing content and tables in one view
Continue












Uncover Actionable Information Inside SEC Filings








Screenshot taken from Lumber Liquidators 10-K Annual Report




Last10K.com Member Feature

Read both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Adobe PDF, Microsoft Word, Excel and CSV Downloads








Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats




Last10K.com Member Feature

Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), Excel (XLSX) and Comma-Delimited (CSV) files for offline viewing, annotations and analysis
Continue












Financial Stability Report








Screenshot of financial stability report for Coco-Cola (2019)




Last10K.com Member Feature

Our Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
Continue












Get a Better Picture of a Company's Performance








Available Financial Ratios




Last10K.com Member Feature

See how over 70 Growth, Profitability and Financial Ratios perform over 10 Years
Continue












See when company executives buy or sell their own stock








Screenshot taken from Euronet (EEFT)




Last10K.com Member Feature

Use our calculated cost dollar values to discover when and how much registered owners BUY, SELL or excercise their company stock OPTIONS aggregated from Form 4 Insider Transactions SEC Filings
Continue












See how institutional managers trade a stock








Screenshot taken from General Motors (GM)




Last10K.com Member Feature

View which hedge funds, pension / retirement funds, endowments, banks and insurance companies have increased or decreased their positions in a particular stock. Includes Ownership Percent, Buy versus Sell comparison, Put-Call ratio and more
Continue












FREE Financial Statements








Screenshot of actual balance sheet from company 10-K Annual Report




Last10K.com Member Feature

Get one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREE












SEC Filing Exhibit
 PDF Download



Loading SEC Filing Exhibit...








SEC Filing Financial Summary
 PDF Download
 Excel Download



Loading SEC Filing Financial Summary...

